期刊文献+

胶质母细胞瘤瘤周水肿药物治疗现状

原文传递
导出
摘要 胶质母细胞瘤引发的瘤周水肿是患者死亡的重要原因之一。但由于瘤周水肿的发病机制复杂,治疗手段单一,针对胶质母细胞瘤的抗水肿治疗通常难以取得理想的疗效。目前,临床主要通过手术切除肿瘤以及应用抗水肿药物来缓解瘤周水肿所致颅内压增高。本文针对瘤周水肿的药物治疗研究现状进行综述。
出处 《中华神经外科杂志》 CSCD 北大核心 2022年第2期210-212,共3页 Chinese Journal of Neurosurgery
基金 内蒙古自然科学基金(2017MS0833) 内蒙古自治区科技计划(2019GG9044) 内蒙古自治区高等学校科学研究项目(NJYZ20141)。
  • 相关文献

参考文献3

二级参考文献36

  • 1Do|ecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report:primary brain and central nervous system tumors diagnosed in the United States in 2005-2009 [ J]. Neuro Oncol, 2012,14 ( Suppl 5 ) : v1-49. DOI : 10. 1093/neuonc/nos218.
  • 2Minniti G, Muni R, Lanzetta G, et al. Chemotherapy for glioblastoma:current treatment and future perspectives for cytotoxic and targeted agents [ J ]. Anticancer Res ,2009 ,29 (12) :5171-5184.
  • 3Wen PY, DeAngelis LM. Chemotherapy for low-grade gliomas: emerging consensus on its benefits [ J]. Neurology ,2007,68 (21) : 1762-1763. DOI : 10.1212/01. wnl. 0000266866.13748. a9.
  • 4Narayana A, Kelly P, Golfinos J, et al. Antiangiogenic therapy using bevacizumab in recurrent high-grade ghoma:impact on local control and patient survival[ J]. J Neurosurg,2009,110( 1 ) :173- 180. DOI : 10.3171/2008.4.17492.
  • 5Folkman J. Tumor angiogensis:role in regulation of tumor growth [J]. Symp Soc Dev Bio1,1974,30(0) :43-52.
  • 6Kreisl TN, Zhang W, Odia Y, et al. A Phase 1I trial of single- agent bevacizumab in patients with recurrent anaplastie glioma [J~. Neuro Oncol, 2011,13 (10) : 1143-1150. DO/: 10. 1093/ neuonc/nor091.
  • 7Nagane M,Nishikawa R,Narita Y,et al. Phase ]/ study of single- agent bevacizumab in Japanese patients with recurrent r~mlignant glioma [ J ]. Jpn J Clin Oncol, 2012,42 ( 10 ) : 887-895. DO1 : 10. 1093/jjco/hys 121.
  • 8Wong ET, Gautam S,Malchow C,et al. Bevacizumab for recurrent glioblastoma multiforme : a meta-analysis [ J ]. J Nat1 Compr Canc Netw,2011,9(4) :403-407.
  • 9Lamborn KR, Yung WK, Chang SM, et al. Progression-free survival:an important end point in evaluating therapy for recurrent high-grade gliomas [ J ]. Neuro Oneol, 2008, 10 ( 2 ) : 162-170. DOI:10. 1215/15228517-20074362.
  • 10Wick W, Puduvalli VK, Chamberlain MC, et al. Phase HI study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblasloma [ J 3. J Clin Onco1,2010,28 ( 7 ) : 1168 1174. DOI : 10.1200/JCO. 2009.23. 2595.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部